The guidance cut is the dominant signal — expect a negative market reaction as the company faces headwinds at Lilly Pulitzer and macro pressure. Monitor upcoming promotional activity and inventory levels; the stock may gap down on the open. Watch for further commentary on the 'broader review' of operations.
Price Chart
Executive Summary
Oxford Industries (OXM) reported Q2 adjusted EPS of $1.34, a modest 2.3% beat vs $1.31 consensus, while revenue of $394.4M was essentially in line with $394.6M. However, the company sharply lowered its full-year fiscal 2026 guidance, now expecting adjusted EPS of $1.60-$2.00 (vs $2.11 in fiscal 2025) and net sales of $1.43B-$1.47B (vs $1.478B), citing softness at Lilly Pulitzer and broader consumer pressure. The guidance cut overshadows the in-line quarter and signals deteriorating fundamentals.
Key Financial Metrics
Key Facts
- Adjusted EPS $1.34 vs consensus $1.31 (beat 2.3%)
- Revenue $394.4M vs consensus $394.6M (in line)
- Revenue declined 2.2% YoY from $403.1M
- Full-year FY2026 adjusted EPS guidance lowered to $1.60-$2.00 from $2.11 in FY2025
- Full-year FY2026 net sales guidance $1.43B-$1.47B vs $1.478B in FY2025
- Lilly Pulitzer sales down 5.6% YoY; Tommy Bahama up 0.8%
- Debt reduced to $73M from $143M at Q1 end, aided by tariff refunds
- Q3 FY2026 guided adjusted loss per share of $1.40-$1.20 vs prior year loss of $0.92
Financial Impact
Guidance cut implies ~15% decline in adjusted EPS from prior year; revenue expected to decline ~2-3% YoY
Risk Factors
- Further deterioration at Lilly Pulitzer and Johnny Was
- Macro consumer spending weakness pressuring apparel demand
- Tariff refunds non-recurring; underlying margins remain pressured
- Potential inventory buildup requiring additional promotions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3356248 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 24, 2026 4w ago | Insider Buy | $25.95 $25.85 | ▼ −0.39% | ▲ +0.36% | $27.77 (+7.01%) |
Sep 15, 2026 5w ago | Insider Cluster | $29.25 $28.93 | ▼ −1.09% | ▼ −2.23% | $27.77 (−5.06%) |
Sep 3, 2026 7w ago | Press Release | $30.87 $31.57 | ▼ −2.27% | ▼ −2.82% | $27.77 (+10.04%) |
Aug 20, 2026 9w ago | Press Release | $36.20 $36.56 | ▲ +0.99% | ▲ +1.29% | $27.77 (−23.29%) |
Jun 10, 2026 19w ago | 8-K | $35.92 $37.24 | ▲ +3.67% | ▲ +3.13% | $27.77 (−22.69%) |
Mar 26, 2026 30w ago | Press Release | $34.12 $35.76 | ▲ +4.79% | ▲ +5.15% | $27.77 (−18.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers